The goals of the Genetic analysis core are: 1) To obtain and process buccal cell specimens from 40,000 participants in the NHS to supplement the DNA obtained from collection; 2) To provide fast, efficient, and accurate genotyping to Project investigators at the lowest possible cost. The core will manage the dispatch of kits for cheek cell collection by mail, and will process and archive these on return; this will be accomplished in Year 1. In years 1-5 we will: 1) Conduct DNA extraction DNA extraction and genotyping for germline polymorphism in CYP1A2, and NAT1, NAT, MnSOD, and MTHFR (Project 1), CYP1A2, NAT1, NAT2, and MTHFR (Project 2), and GALT and AR (Project 3). Germline DNA will be extracted from stored buffy goats, cheek cell samples, and normal tissue from tumor blocks; 2) Assess methylation status of CpG islands in the promoter regions of ER and p16 (Project 1) and p16 (Project 2). The existence of the Core will permit genotyping to proceed, efficiently, and additional efficiencies will be achieved as several of the genotypes overlap between the projects permitting some economies of scale. The minimal geographic separation of the core facility from the investigators will also facilitate rapid communication of priorities for analyses, speedy interpretation of results of and resolution of any questions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA087969-03
Application #
6595023
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
3
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Chiu, Yu-Han; Bertrand, Kimberly A; Zhang, Shumin et al. (2018) A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma. Int J Cancer 143:1914-1922
Wang, Xiaoliang; Chan, Andrew T; Slattery, Martha L et al. (2018) Influence of Smoking, Body Mass Index, and Other Factors on the Preventive Effect of Nonsteroidal Anti-Inflammatory Drugs on Colorectal Cancer Risk. Cancer Res 78:4790-4799
Petrick, Jessica L; Campbell, Peter T; Koshiol, Jill et al. (2018) Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer 118:1005-1012
He, Xiaosheng; Wu, Kana; Ogino, Shuji et al. (2018) Association Between Risk Factors for Colorectal Cancer and Risk of Serrated Polyps and Conventional Adenomas. Gastroenterology 155:355-373.e18
Park, Min Kyung; Li, Wen-Qing; Qureshi, Abrar A et al. (2018) Fat Intake and Risk of Skin Cancer in U.S. Adults. Cancer Epidemiol Biomarkers Prev 27:776-782
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096
Kim, Hanseul; Keum, NaNa; Giovannucci, Edward L et al. (2018) Garlic intake and gastric cancer risk: Results from two large prospective US cohort studies. Int J Cancer 143:1047-1053
Reeves, Katherine W; Okereke, Olivia I; Qian, Jing et al. (2018) Depression, Antidepressant Use, and Breast Cancer Risk in Pre- and Postmenopausal Women: A Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev 27:306-314
Liu, Li; Tabung, Fred K; Zhang, Xuehong et al. (2018) Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum. Clin Gastroenterol Hepatol 16:1622-1631.e3
Lin, Brian M; Li, Wen-Qing; Cho, Eunyoung et al. (2018) Statin use and risk of skin cancer. J Am Acad Dermatol 78:682-693

Showing the most recent 10 out of 1708 publications